2004
DOI: 10.1016/j.nbd.2003.09.016
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
83
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 141 publications
(89 citation statements)
references
References 47 publications
6
83
0
Order By: Relevance
“…Reports have indicated that the function of NMDARs decreases in AD, including gene expression (Yashiro and Philpot, 2008), levels of mRNA and protein (Hynd et al, 2001), or neurotransmitters (Rupsingh et al, 2011). A decline in levels of NMDAR subunits has been observed in many AD models and clinical research (Hynd et al, 2004;Mishizen-Eberz et al, 2004;Kravitz et al, 2013), which is consistent with our result that NMDAR1 and NMDAR2B expression decreased in SAMP8 as compared with SAMR1 mice. The decreased level of NMDAR limited its normal functional role, leading to a deficit in learning and memory.…”
Section: Hps Treatment Reverses the Changes In Level Of Nmda Subunitssupporting
confidence: 91%
“…Reports have indicated that the function of NMDARs decreases in AD, including gene expression (Yashiro and Philpot, 2008), levels of mRNA and protein (Hynd et al, 2001), or neurotransmitters (Rupsingh et al, 2011). A decline in levels of NMDAR subunits has been observed in many AD models and clinical research (Hynd et al, 2004;Mishizen-Eberz et al, 2004;Kravitz et al, 2013), which is consistent with our result that NMDAR1 and NMDAR2B expression decreased in SAMP8 as compared with SAMR1 mice. The decreased level of NMDAR limited its normal functional role, leading to a deficit in learning and memory.…”
Section: Hps Treatment Reverses the Changes In Level Of Nmda Subunitssupporting
confidence: 91%
“…4,5) It has been reported that NR1 and NR2B mRNA levels decrease in patients with AD associated with progression of the neuropathology. 10) We reported previously that CRE-dependent transcription was enhanced by nobiletin by activation of the PKA/MEK/ERK/ CREB signal pathway in PC12D cells. 15,20) Moreover, our previous report showed that nobiletin ameliorates the NMDA receptor antagonist-induced learning impairment in association with ERK activation in mice.…”
Section: Discussionmentioning
confidence: 91%
“…9) Furthermore, NR1 and NR2B subunit mRNA and protein levels decrease significantly in patients with AD, and the degree of decrease is associated with progression of the neuropathology. 10) Recent studies have demonstrated that learning and memory requires expression of large number of genes that are associated with the cAMP response element (CRE)-binding protein (CREB). [11][12][13] Elevated Ca 2+ level then triggers multiple protein kinase signal pathways that activate LTP by activating protein kinase A (PKA)/mitogen-activated protein kinase (MAPK) kinase (MEK)/MAPK/CREB.…”
mentioning
confidence: 99%
“…The overlap of these changes with those of Alzheimer´s pathology suggests that low dose rate irradiation may be involved in the development of Alzheimer´s disease [7]. In the United States, analysis of AD death rates versus radon background radiation and total background angiogenesis [18], up-regulation of NMDA receptor subunit 1 (NR1) and NR2A [19], changes of synaptic proteins such as MAP-2 and PSD-95 [20], accumulation of ubiquitin inclusion bodies, autophagosome [21] and down-regulation of neurotrophic factors such as brainderived neurotrophic factor (BDNF) [22] may induce neuritic plaques, neurofibritlary tangles and neuropil threads leading to the development of Alzheimer's disease (Figure 1). …”
mentioning
confidence: 99%